Androgen receptor-negative prostate cancer is vulnerable to SWI/SNF-targeting degrader molecules
收藏官方服务：
资源简介：
WCM1078 cell line treated with a PROTAC targeting SMARCA2 and SMARCA4.A947: active compoundA858: inactive compound (control) scRNA folder also includes MSK-PCa16 cell line.
提供机构：
Zenodo创建时间：
2025-04-23
